SpringLoc
Personalized Breast Conservation Surgery System
Company Overview
Snapshot
Founded in December 2020 by David Nitsan, SpringLoc operates with 1–10 employees. The company holds one patent and is currently in the R&D product stage, focusing on developing its SpringLoc AR product.
Business overview
SpringLoc is revolutionizing Breast-Conserving Surgeries, specifically Lumpectomies, by developing a personalized system centered on Augmented Reality (AR) technology. The company's core product, SpringLoc AR, involves the development and implementation of proprietary smart breast markers to provide a distinctive solution in breast surgery. SpringLoc operates within the Health Tech & Life Sciences sector, serving the Medical Devices and Digital Healthcare industries, with a primary focus on the North American and European geomarkets.
Company Intelligence Q&A
- What is SpringLoc's primary focus?
- SpringLoc is focused on revolutionizing Breast-Conserving Surgeries, particularly Lumpectomies, through the application of Augmented Reality (AR) technology.
- When was SpringLoc founded?
- SpringLoc was founded in December 2020.
- Who is the founder of SpringLoc?
- David Nitsan is the Founder & CEO of SpringLoc.
- What is SpringLoc's main product?
- SpringLoc's main product is SpringLoc AR, which involves proprietary smart breast markers for breast surgery.
- In which markets does SpringLoc operate?
- SpringLoc operates in the North American and European geomarkets, targeting the Medical Devices Industry within the Healthcare & Life Sciences sector.